Basilea Pharmaceutica AG (BSLN) — Net Asset Quality Index
Basilea Pharmaceutica AG (BSLN) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF282.00 Million minus total liabilities of CHF154.06 Million yields net assets of CHF127.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Basilea Pharmaceutica AG (BSLN) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Basilea Pharmaceutica AG Net Asset Quality Index Over Time (2002–2025)
This chart shows how Basilea Pharmaceutica AG's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of CHF127.94 Million against total assets of CHF282.00 Million CHF. For live market cap and overall valuation, see BSLN stock market capitalisation.
Annual Net Asset Quality Index for Basilea Pharmaceutica AG (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Basilea Pharmaceutica AG from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BSLN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.4% | CHF127.94 Million | CHF282.00 Million | CHF154.06 Million | ▲ +13.9 pp |
| 2024 | 31.4% | CHF81.00 Million | CHF257.76 Million | CHF176.76 Million | ▲ +37.2 pp |
| 2023 | -5.8% | CHF-10.00 Million | CHF173.29 Million | CHF183.29 Million | ▲ +3.6 pp |
| 2022 | -9.4% | CHF-20.71 Million | CHF220.85 Million | CHF241.56 Million | ▲ +14.3 pp |
| 2021 | -23.7% | CHF-58.61 Million | CHF247.27 Million | CHF305.87 Million | ▲ +20.7 pp |
| 2020 | -44.4% | CHF-102.05 Million | CHF229.79 Million | CHF331.84 Million | ▼ -2.4 pp |
| 2019 | -42.0% | CHF-92.96 Million | CHF221.47 Million | CHF314.43 Million | ▼ -18.3 pp |
| 2018 | -23.7% | CHF-66.69 Million | CHF281.75 Million | CHF348.44 Million | ▼ -11.9 pp |
| 2017 | -11.8% | CHF-41.44 Million | CHF351.17 Million | CHF392.61 Million | ▼ -1.1 pp |
| 2016 | -10.7% | CHF-35.00 Million | CHF327.76 Million | CHF362.76 Million | ▼ -14.4 pp |
| 2015 | 3.7% | CHF14.86 Million | CHF398.74 Million | CHF383.88 Million | ▼ -18.8 pp |
| 2014 | 22.5% | CHF57.93 Million | CHF257.38 Million | CHF199.45 Million | ▼ -1.1 pp |
| 2013 | 23.6% | CHF70.87 Million | CHF299.76 Million | CHF228.88 Million | ▼ -4.5 pp |
| 2012 | 28.1% | CHF105.50 Million | CHF375.34 Million | CHF269.84 Million | ▼ -36.5 pp |
| 2011 | 64.6% | CHF153.27 Million | CHF237.09 Million | CHF83.82 Million | ▼ -1.8 pp |
| 2010 | 66.4% | CHF210.24 Million | CHF316.54 Million | CHF106.30 Million | ▲ +19.1 pp |
| 2009 | 47.3% | CHF97.73 Million | CHF206.61 Million | CHF108.88 Million | ▼ -13.6 pp |
| 2008 | 60.9% | CHF199.74 Million | CHF328.13 Million | CHF128.38 Million | ▼ -11.7 pp |
| 2007 | 72.6% | CHF335.10 Million | CHF461.45 Million | CHF126.34 Million | ▲ +17.3 pp |
| 2006 | 55.3% | CHF112.31 Million | CHF203.09 Million | CHF90.78 Million | ▼ -10.4 pp |
| 2005 | 65.7% | CHF167.87 Million | CHF255.56 Million | CHF87.69 Million | ▼ -25.1 pp |
| 2004 | 90.8% | CHF209.60 Million | CHF230.78 Million | CHF21.18 Million | ▲ +6.5 pp |
| 2003 | 84.4% | CHF90.29 Million | CHF107.02 Million | CHF16.73 Million | ▲ +1.1 pp |
| 2002 | 83.3% | CHF125.38 Million | CHF150.51 Million | CHF25.13 Million | — |